Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System

Common Immune-Related Adverse Events of Immune Checkpoint Inhibitors in the Gastrointestinal System: A Study Based on the US Food and Drug Administration Adverse Event Reporting System

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment; however, immune-related adverse events (irAEs) in the gastrointestinal (GI) system commonly occur. In this study, data were obtained from the US Food and Drug Administration adverse event reporting system between July 2014 and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Xiaoyin Bai, Shiyu Jiang, Yangzhong Zhou, Hongnan Zhen, Junyi Ji, Yi Li, Gechong Ruan, Yang Yang, Kaini Shen, Luo Wang, Guanqiao Li, Hong Yang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
immune checkpoint inhibitors
digestive toxicities
fares
cancer
side effects
Therapeutics. Pharmacology
RM1-950
Acceso en línea:https://doaj.org/article/03083c085dc44e8e9fc6f9ceef38167d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/03083c085dc44e8e9fc6f9ceef38167d

Ejemplares similares